N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide

C19H30N6O3 — CID 109075775

IUPACN-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide
SMILESCN(C)CCCNC(=O)c1nc(C(=O)N2CCN(C=O)CC2)n2c1CCCC2
InChIInChI=1S/C19H30N6O3/c1-22(2)8-5-7-20-18(27)16-15-6-3-4-9-25(15)17(21-16)19(28)24-12-10-23(14-26)11-13-24/h14H,3-13H2,1-2H3,(H,20,27)
InChIKeyPZKGOPLJTYKQAE-UHFFFAOYSA-N
MW390.49 g/mol
LogP-0.18
Rot. Bonds7

About N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide

N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide (PubChem CID 109075775) has the molecular formula C19H30N6O3 and a molecular weight of 390.49 g/mol. Its IUPAC name is N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide.

Molecular Properties

Compound NameN-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide
PubChem CID109075775
Molecular FormulaC19H30N6O3
Molecular Weight390.49 g/mol
Exact Mass390.24
IUPAC NameN-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide
SMILESCN(C)CCCNC(=O)c1nc(C(=O)N2CCN(C=O)CC2)n2c1CCCC2
InChIInChI=1S/C19H30N6O3/c1-22(2)8-5-7-20-18(27)16-15-6-3-4-9-25(15)17(21-16)19(28)24-12-10-23(14-26)11-13-24/h14H,3-13H2,1-2H3,(H,20,27)
InChIKeyPZKGOPLJTYKQAE-UHFFFAOYSA-N
XLogP-0.18
TPSA90.78 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500390.49
LogP ≤ 5-0.18
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide?
The IUPAC name of N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide (CID 109075775) is N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide.
What is the SMILES notation for N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide?
The canonical SMILES for N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide is CN(C)CCCNC(=O)c1nc(C(=O)N2CCN(C=O)CC2)n2c1CCCC2.
What is the InChIKey of N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide?
The InChIKey is PZKGOPLJTYKQAE-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H30N6O3/c1-22(2)8-5-7-20-18(27)16-15-6-3-4-9-25(15)17(21-16)19(28)24-12-10-23(14-26)11-13-24/h14H,3-13H2,1-2H3,(H,20,27).
What are the key properties of N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide?
N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide has a molecular weight of 390.49 g/mol, XLogP of -0.18, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(dimethylamino)propyl]-3-(4-formylpiperazine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-1-carboxamide is sourced from PubChem (CID 109075775), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).